Outcomes of Treat-and-Extend versus Pro Re Nata Anti-VEGF Injections for Myopic Macular Neovascularization in Patients in the United States

被引:0
作者
Swaminathan, Shreya [1 ]
Mahmoudzadeh, Raziyeh [2 ]
Wakabayashi, Taku [2 ]
Bowers, Mallory Elva [1 ]
Abishek, Robert [2 ]
Salabati, Mirataollah [2 ]
Hsu, Jason [2 ]
Dunn, James P. [2 ]
机构
[1] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA USA
[2] Wills Eye Hosp & Res Inst, Philadelphia, PA USA
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
[21]   REAL WORLD OUTCOMES OF TREAT-AND-EXTEND AND PRO RE NATA DOSING STRATEGIES VERSUS MONTHLY DOSING FOR NEOVASCULAR AGE RELATED MACULAR DEGENERATION USING RANIBIZUMAB: A LITERATURE REVIEW AND ECONOMIC ANALYSIS [J].
Rufai, S. R. ;
Hamami, H. .
EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2017, 27 (02) :E83-E83
[22]   Treat-and-extend dosing of intravitreal anti-VEGF agents in neovascular age-related macular degeneration: a meta-analysis [J].
Nichani, Prem A. H. ;
Popovic, Marko M. ;
Dhoot, Arjan S. ;
Pathak, Ananya ;
Muni, Rajeev H. ;
Kertes, Peter J. .
EYE, 2023, 37 (14) :2855-2863
[23]   Treat-and-extend dosing of intravitreal anti-VEGF agents in neovascular age-related macular degeneration: a meta-analysis [J].
Prem A. H. Nichani ;
Marko M. Popovic ;
Arjan S. Dhoot ;
Ananya Pathak ;
Rajeev H. Muni ;
Peter J. Kertes .
Eye, 2023, 37 :2855-2863
[24]   Influence of posterior vitreous detachment on extendability of treat-and-extend anti-VEGF therapy in neovascular age-related macular degeneration [J].
Klimscha, Sophie ;
Coulibaly, Leon ;
Sadeghipour, Amir ;
Gerendas, Bianca S. ;
Waldstein, Sebastian M. ;
Schmidt-Erfurth, Ursula .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
[25]   Comparison of Outcomes in Patients with Neovascular Age-Related Macular Degeneration Managed with Anti-VEGF on Conventional Treat-and-Extend vs. Trial-Stop Regimens [J].
Weng, Christina Y. ;
Lin, Weijie Violet .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
[26]   Changes in metamorphopsia after the treat-and-extend regimen of anti-VEGF therapy for macular edema associated with branch retinal vein occlusion [J].
Mori, Kenichiro ;
Ishikawa, Keijiro ;
Wada, Iori ;
Kubo, Yuki ;
Kobayashi, Yoshiyuki ;
Nakama, Takahito ;
Haruta, Masatoshi ;
Akiyama, Masato ;
Nakao, Shintaro ;
Yoshida, Shigeo ;
Sonoda, Koh-Hei .
PLOS ONE, 2020, 15 (10)
[27]   Treatment Cessation in Patients with Diabetic Maculopathy under Intravitreal Anti-VEGF Therapy Following a Treat-and-Extend Protocol [J].
Saucedo, Lucia ;
Pfister, Isabel B. ;
Schild, Christin ;
Garweg, Justus G. .
OPHTHALMOLOGY SCIENCE, 2025, 5 (06)
[28]   The Impact of Interval between Recurrence and Reinjection in Anti-VEGF Therapy for Diabetic Macular Edema in Pro Re Nata Regimen [J].
Takamura, Yoshihiro ;
Kida, Teruyo ;
Noma, Hidetaka ;
Inoue, Makoto ;
Yoshida, Shigeo ;
Nagaoka, Taiji ;
Noda, Kousuke ;
Yamada, Yutaka ;
Morioka, Masakazu ;
Gozawa, Makoto ;
Matsumura, Takehiro ;
Inatani, Masaru .
JOURNAL OF CLINICAL MEDICINE, 2021, 10 (24)
[29]   Anti-VEGF injection frequency correlates with visual acuity outcomes in pro re nata neovascular AMD treatment [J].
Wecker, Thomas ;
Grundel, Bastian ;
Reichl, Sabine ;
Stech, Milena ;
Lange, Clemens ;
Agostini, Hansjuergen ;
Boehringer, Daniel ;
Stahl, Andreas .
SCIENTIFIC REPORTS, 2019, 9 (1)
[30]   Anti-VEGF injection frequency correlates with visual acuity outcomes in pro re nata neovascular AMD treatment [J].
Thomas Wecker ;
Bastian Grundel ;
Sabine Reichl ;
Milena Stech ;
Clemens Lange ;
Hansjürgen Agostini ;
Daniel Böhringer ;
Andreas Stahl .
Scientific Reports, 9